OncoCyte Balance Sheet Health
Financial Health criteria checks 4/6
OncoCyte has a total shareholder equity of $16.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $71.0M and $54.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$5.58m |
Equity | US$16.92m |
Total liabilities | US$54.05m |
Total assets | US$70.97m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7OC0's short term assets ($6.5M) do not cover its short term liabilities ($8.3M).
Long Term Liabilities: 7OC0's short term assets ($6.5M) do not cover its long term liabilities ($45.7M).
Debt to Equity History and Analysis
Debt Level: 7OC0 is debt free.
Reducing Debt: 7OC0 has no debt compared to 5 years ago when its debt to equity ratio was 2.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7OC0 has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 7OC0 is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.